News-Medical reports that the diabetes and weight loss medicines may also lower the chance of serious complications in the recovery period after an operation.
Recap by typeshit. Full story at News-Medical.Net.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
18:05
Dr. Stirrett walks through three pointers for people on tirzepatide, framed as part of a broader GLP-1 guide. His advice, not a set protocol.
He walks through an Azoury et al study in the October 2026 Plastic and Reconstructive Surgery that uses global health network data to compare the two weight loss routes.
The claim credits GLP-1 drugs' effects on insulin sensitivity and inflammation for changes in dermatologic conditions. No study is cited.
Bahrain's health regulator has cleared the pill form of semaglutide, following the UAE as the second Gulf state to make it available.
The TRANSCEND-T2D-1 results in The Lancet covered 537 adults over 40 weeks, with HbA1c falling as much as 1.94 points at the top 12 mg dose versus placebo.
Loading…